Axsome Therapeutics AXSM Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$64.54M-126% | -$28.56M+39.5% | -$47.23M+1.6% | -$47.97M+19.3% | -$59.41M+20.7% | ||
| $116K+1.8% | $114K-5.0% | $120K0.0% | $120K-19.5% | $149K+15.5% | ||
| $23.44M+3.1% | $22.73M-1.6% | $23.1M-6.1% | $24.61M+5.6% | $23.31M+6.0% | ||
| -$20.7M-11.0% | -$18.65M— | $0+100% | -$32.42M+25.2% | -$43.38M-65.5% | ||
| $121K+70.4% | $71K+22.4% | $58K+346% | $13K-96.2% | $338K+1,027% | ||
| -$121K-70.4% | -$71K-22.4% | -$58K-346% | -$13K+96.2% | -$338K-1,027% | ||
| $70M0.0% | $70M0.0% | $70M— | —— | —— | ||
| $2.99M-81.7% | $16.39M-23.0% | $21.27M-38.4% | $34.54M+18.0% | $29.27M+105% | ||
| -$17.83M— | —— | $22.26M— | —— | -$14.44M-20.5% | ||
| -$20.82M-11.2% | -$18.72M— | $0+100% | -$32.44M+25.8% | -$43.71M-66.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Axsome Therapeutics generate?
- Axsome Therapeutics (AXSM) generated -$71.8M in operating cash flow over the trailing twelve months.
- What is Axsome Therapeutics's free cash flow?
- After $263.0K of capital expenditures, Axsome Therapeutics's free cash flow was -$72.0M over the trailing twelve months, up 39.4% year over year.
- Where does Axsome Therapeutics's cash flow data come from?
- Every line is extracted from Axsome Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
